BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhou J, Fan J, Wang Z, Wu ZQ, Qiu SJ, Huang XW, Yu Y, Sun J, Xiao YS, He YF, Wang YQ, Tang ZY. Conversion to sirolimus immunosuppression in liver transplantation recipients with hepatocellular carcinoma: Report of an initial experience. World J Gastroenterol 2006; 12(19): 3114-3118 [PMID: 16718799 DOI: 10.3748/wjg.v12.i19.3114]
URL: https://www.wjgnet.com/1007-9327/full/v12/i19/3114.htm
Number Citing Articles
1
Gerhard Treiber, Thomas Wex. Targeted Therapies for Hepatocellular Carcinoma2011; : 44 doi: 10.2217/ebo.11.316
2
T. Decaens, M. Hurtova, C. Duvoux. Transplantation hépatique pour carcinome hépatocellulaireGastroentérologie Clinique et Biologique 2009; 33(1): 61 doi: 10.1016/j.gcb.2008.11.005
3
Celina Ang, Eileen M. O’Reilly, Ghassan K. Abou-Alfa. Multidisciplinary Treatment of Hepatocellular CarcinomaRecent Results in Cancer Research 2013; 190: 225 doi: 10.1007/978-3-642-16037-0_15
4
K. V. Menon, A. R. Hakeem, N. D. Heaton. Meta‐analysis: recurrence and survival following the use of sirolimus in liver transplantation for hepatocellular carcinomaAlimentary Pharmacology & Therapeutics 2013; 37(4): 411 doi: 10.1111/apt.12185
5
Mamatha Bhat, Elisa Pasini, Preya Patel, Jeffrey Yu, Cristina Baciu, Sunil M. Kurian, Josh Levitsky. Achieving tolerance modifies cancer susceptibility profiles in liver transplant recipientsCancer Medicine 2023; 12(4): 5150 doi: 10.1002/cam4.5271
6
Utz Settmacher, Falk Rauchfuß, Michael Bauer, Astrid Bauschke, Susanne Beckebaum, Alfred Königsrainer, Christina Malessa, Silvio Nadalin, Silke Rummler, Andreas Kortgen, Lara Genedy. Organtransplantation mit Lebendspende2023; : 129 doi: 10.1007/978-3-662-65736-2_8
7
Taha Z. Shipchandler, Robert R. Lorenz, Walter T. Lee, Aysenur Meric Teker, Olivia Dan, Marshall Strome. Laryngeal Transplantation in the Setting of Cancer: A Rat ModelThe Laryngoscope 2008; 118(12): 2166 doi: 10.1097/MLG.0b013e3181855108
8
Quan-Lin Li, Fang-Ming Gu, Zheng Wang, Jia-Hao Jiang, Li-Qing Yao, Chang-Jun Tan, Xiao-Yong Huang, Ai-Wu Ke, Zhi Dai, Jia Fan, Jian Zhou, Xin-yuan Guan. Activation of PI3K/AKT and MAPK Pathway through a PDGFRβ-Dependent Feedback Loop Is Involved in Rapamycin Resistance in Hepatocellular CarcinomaPLoS ONE 2012; 7(3): e33379 doi: 10.1371/journal.pone.0033379
9
Krishna Menon, Aarathi Vijayashanker, Jamie Murphy, Pål-Dag Line, John Isaac, Anya Adair, Raj Prasad, Douglas Thorburn, Anya Adair, Ian Parker, Lindy Berkman, William Gelson, Rebecca Jones, Derek Manas, Gary Middleton, Jamie Murphy, Praveen Peddu, John Isaac, Thamara Perera, Raj Prasad, Joerg Pollok, Andrew Scarsbrook, Yoh Zen. Liver transplantation for isolated unresectable colorectal liver metastases - Protocol for a service evaluation in the United Kingdom - UKCoMET studyHPB 2023; 25(6): 684 doi: 10.1016/j.hpb.2023.02.011
10
Michael A. Zimmerman, James F. Trotter, Michael Wachs, Thomas Bak, Jeffrey Campsen, Franklin Wright, Tracy Steinberg, William Bennett, Igal Kam. Predictors of long-term outcome following liver transplantation for hepatocellular carcinoma: a single-center experienceTransplant International 2007; 20(9): 747 doi: 10.1111/j.1432-2277.2007.00505.x
11
Mandana Rastegar, Haji-Amin Marjani, Yaghoub Yazdani, Majid Shahbazi, Masoud Golalipour, Touraj Farazmandfar. Investigating Effect of Rapamycin and Metformin on Angiogenesis in Hepatocellular Carcinoma Cell LineAdvanced Pharmaceutical Bulletin 2018; 8(1): 63 doi: 10.15171/apb.2018.008
12
Myron Schwartz, Sasan Roayaie, Manousos Konstadoulakis. Strategies for the management of hepatocellular carcinomaNature Clinical Practice Oncology 2007; 4(7): 424 doi: 10.1038/ncponc0844
13
Daniel Palmes, Andree Zibert, Tymotheus Budny, Ralf Bahde, Evgeny Minin, Linus Kebschull, Jens Hölzen, Hartmut Schmidt, Hans-Ullrich Spiegel. Impact of rapamycin on liver regenerationVirchows Archiv 2008; 452(5): 545 doi: 10.1007/s00428-008-0604-y
14
Toshiyasu Kawahara, Sonal Asthana, Norman M. Kneteman. m-TOR inhibitors: What role in liver transplantation?Journal of Hepatology 2011; 55(6): 1441 doi: 10.1016/j.jhep.2011.06.015
15
Angel Rubín, Marina Berenguer. Trasplante hepático: inmunosupresión personalizada en pacientes con hepatitis C y carcinoma hepatocelularGastroenterología y Hepatología 2013; 36(1): 48 doi: 10.1016/j.gastrohep.2012.03.006
16
Thomas Decaens, Alain Luciani, Emmanuel Itti, Anne Hulin, Françoise Roudot-Thoraval, Alexis Laurent, Elie Serge Zafrani, Ariane Mallat, Christophe Duvoux. Phase II study of sirolimus in treatment-naive patients with advanced hepatocellular carcinomaDigestive and Liver Disease 2012; 44(7): 610 doi: 10.1016/j.dld.2012.02.005
17
Andreas A. Schnitzbauer, Hans J. Schlitt, Edward K. Geissler. Influence of Immunosuppressive Drugs on the Recurrence of Hepatocellular Carcinoma After Liver Transplantation: A Gap Between Basic Science and Clinical EvidenceTransplantation 2011; 91(11): 1173 doi: 10.1097/TP.0b013e318215e72b
18
Tonghai Xing, Li Huang, Zhenhai Yu, Lin Zhong, Shuyun Wang, Zhihai Peng, Peter Starkel. Comparison of Steroid-Free Immunosuppression and Standard Immunosuppression for Liver Transplant Patients with Hepatocellular CarcinomaPLoS ONE 2013; 8(8): e71251 doi: 10.1371/journal.pone.0071251
19
Yasunobu Matsuda, Takafumi Ichida, Manabu Fukumoto. Hepatocellular carcinoma and liver transplantation: clinical perspective on molecular targeted strategiesMedical Molecular Morphology 2011; 44(3): 117 doi: 10.1007/s00795-011-0547-2
20
Jeffrey Campsen, Michael A Zimmerman, James F Trotter, Michael Wachs, Thomas Bak, Susan Mandell, Igal Kam. Sirolimus and liver transplantation: clinical implications for hepatocellular carcinomaExpert Opinion on Pharmacotherapy 2007; 8(9): 1275 doi: 10.1517/14656566.8.9.1275
21
Jia Fan, Guang-Shun Yang, Zhi-Ren Fu, Zhi-Hai Peng, Qiang Xia, Chen-Hong Peng, Jian-Ming Qian, Jian Zhou, Yang Xu, Shuang-Jian Qiu, Lin Zhong, Guang-Wen Zhou, Jian-Jun Zhang. Liver transplantation outcomes in 1,078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, ChinaJournal of Cancer Research and Clinical Oncology 2009; 135(10): 1403 doi: 10.1007/s00432-009-0584-6
22
M. Schöniger‐Hekele, C. Müller. Pilot study: rapamycin in advanced hepatocellular carcinomaAlimentary Pharmacology & Therapeutics 2010; 32(6): 763 doi: 10.1111/j.1365-2036.2010.04404.x
23
Hae Won Lee, Kyung-Suk Suh. Advancements of liver transplantation for hepatocellular carcinoma in KoreaJapanese Journal of Clinical Oncology 2017; 47(2): 93 doi: 10.1093/jjco/hyw168
24
J. Zhou, Z. Wang, Z.-Q. Wu, S.-J. Qiu, Y. Yu, X.-W. Huang, Z.-Y. Tang, J. Fan. Sirolimus-Based Immunosuppression Therapy in Liver Transplantation for Patients With Hepatocellular Carcinoma Exceeding the Milan CriteriaTransplantation Proceedings 2008; 40(10): 3548 doi: 10.1016/j.transproceed.2008.03.165
25
Khaldoun Ghazal, Fabien Stenard, Géraldine Dahlqvist, Clément Barjon, Lynda Aoudjehane, Olivier Scatton, Filomena Conti. Treatment with mTOR inhibitors after liver transplantation enables a sustained increase in regulatory T-cells while preserving their suppressive capacityClinics and Research in Hepatology and Gastroenterology 2018; 42(3): 237 doi: 10.1016/j.clinre.2017.10.001
26
Anthony P. Monaco. The Role of mTOR Inhibitors in the Management of Posttransplant MalignancyTransplantation 2009; 87(2): 157 doi: 10.1097/TP.0b013e318193886e
27
Srinath Chinnakotla, Gary L. Davis, Sugam Vasani, Peter Kim, Koji Tomiyama, Edmund Sanchez, Nicholas Onaca, Robert Goldstein, Marlon Levy, Göran B. Klintmalm. Impact of sirolimus on the recurrence of hepatocellular carcinoma after liver transplantationLiver Transplantation 2009; 15(12): 1834 doi: 10.1002/lt.21953
28
Laura M. Kulik, Mary F. Mulcahy, Reed A. Omary, Riad Salem. Emerging Approaches in Hepatocellular CarcinomaJournal of Clinical Gastroenterology 2007; 41(9): 839 doi: 10.1097/MCG.0b013e318060ac52
29
Monika Hurtova, Thomas Decaens, Alexis Laurent, Daniel Cherqui, Christophe Duvoux. Transplantation hépatique pour carcinome hépatocellulaire et chez les malades avec antécédents de cancerLa Presse Médicale 2009; 38(9): 1272 doi: 10.1016/j.lpm.2009.05.001
30
Peng‐Xiang Wang, Yang Xu, Yun‐Fan Sun, Jian‐Wen Cheng, Kai‐Qian Zhou, Sui‐Yi Wu, Bo Hu, Ze‐Fan Zhang, Wei Guo, Ya Cao, Xiao‐Wu Huang, Jian Zhou, Jia Fan, Xin‐Rong Yang. Detection of circulating tumour cells enables early recurrence prediction in hepatocellular carcinoma patients undergoing liver transplantationLiver International 2021; 41(3): 562 doi: 10.1111/liv.14734
31
Lee S. Nguyen, Mathieu Vautier, Yves Allenbach, Noel Zahr, Olivier Benveniste, Christian Funck-Brentano, Joe-Elie Salem. Sirolimus and mTOR Inhibitors: A Review of Side Effects and Specific Management in Solid Organ TransplantationDrug Safety 2019;  doi: 10.1007/s40264-019-00810-9
32
Wolfgang Sieghart, Thorsten Fuereder, Katharina Schmid, Daniel Cejka, Johannes Werzowa, Fritz Wrba, Xiaowei Wang, Diego Gruber, Susanne Rasoul-Rockenschaub, Markus Peck-Radosavljevic, Volker Wacheck. Mammalian Target of Rapamycin Pathway Activity in Hepatocellular Carcinomas of Patients Undergoing Liver TransplantationTransplantation 2007; 83(4): 425 doi: 10.1097/01.tp.0000252780.42104.95
33
T. Decaens, C. Duvoux. Carcinome hépatocellulaire et transplantation hépatique : rôle futur des inhibiteurs de la mTORGastroentérologie Clinique et Biologique 2009; 33: S257 doi: 10.1016/S0399-8320(09)73163-X
34
Edward K. Geissler, Andreas A. Schnitzbauer, Carl Zülke, Philipp E. Lamby, Andrea Proneth, Christophe Duvoux, Patrizia Burra, Karl-Walter Jauch, Markus Rentsch, Tom M. Ganten, Jan Schmidt, Utz Settmacher, Michael Heise, Giorgio Rossi, Umberto Cillo, Norman Kneteman, René Adam, Bart van Hoek, Philippe Bachellier, Philippe Wolf, Lionel Rostaing, Wolf O. Bechstein, Magnus Rizell, James Powell, Ernest Hidalgo, Jean Gugenheim, Heiner Wolters, Jens Brockmann, André Roy, Ingrid Mutzbauer, Angela Schlitt, Susanne Beckebaum, Christian Graeb, Silvio Nadalin, Umberto Valente, Victor Sánchez Turrión, Neville Jamieson, Tim Scholz, Michele Colledan, Fred Fändrich, Thomas Becker, Gunnar Söderdahl, Olivier Chazouillères, Heikki Mäkisalo, Georges-Philippe Pageaux, Rudolf Steininger, Thomas Soliman, Koert P. de Jong, Jacques Pirenne, Raimund Margreiter, Johann Pratschke, Antonio D. Pinna, Johann Hauss, Stefan Schreiber, Simone Strasser, Jürgen Klempnauer, Roberto I. Troisi, Sherrie Bhoori, Jan Lerut, Itxarone Bilbao, Christian G. Klein, Alfred Königsrainer, Darius F. Mirza, Gerd Otto, Vincenzo Mazzaferro, Peter Neuhaus, Hans J. Schlitt. Sirolimus Use in Liver Transplant Recipients With Hepatocellular CarcinomaTransplantation 2016; 100(1): 116 doi: 10.1097/TP.0000000000000965
35
Maria Pleguezuelo, Giacomo Germani, Andrew K Burroughs. Evidence‐Based Gastroenterology and Hepatology2010; : 685 doi: 10.1002/9781444314403.ch42
36
Oriol Bestard, Josep M. Cruzado, Josep M. Grinyó. Textbook of Organ Transplantation2014; : 1134 doi: 10.1002/9781118873434.ch95
37
Nicholas Onaca, Marvin J. Stone, James M. Fulmer, Göran B.G. Klintmalm. Transplantation of the Liver2015; : 189 doi: 10.1016/B978-1-4557-0268-8.00016-6
38
Claudia E. Falkensammer, Hugo Bonatti, Juergen Falkensammer, Jaime Aranda-Michel, Rolland C. Dickson, Kelly Norman, Ronald Hinder, Thomas Gonwa, Jeffrey Steers, Winston Hewitt, Justin H. Nguyen. Combined liver transplantation together with partial/total nephrectomy in patients with renal cell cancer and nonalcoholic steatohepatitisTransplant International 2007; 20(5): 471 doi: 10.1111/j.1432-2277.2006.00442.x
39
Guang-Han Fan, Chen-Zhi Zhang, Feng-Qiang Gao, Xu-Yong Wei, Sun-Bin Ling, Kai Wang, Jian-Guo Wang, Shu-Sen Zheng, Mehrdad Nikfarjam, Xiao Xu. A mixed blessing for liver transplantation patients — RapamycinHepatobiliary & Pancreatic Diseases International 2023; 22(1): 14 doi: 10.1016/j.hbpd.2022.10.004
40
Michael A. Zimmerman, James F. Trotter, Michael Wachs, Tom Bak, Jeffrey Campsen, Afshin Skibba, Igal Kam. Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinomaLiver Transplantation 2008; 14(5): 633 doi: 10.1002/lt.21420
41
Jennifer Kim, Eric Huang, Linda Sher, Jose L Almeda. The role of sirolimus in liver transplantationCurrent Opinion in Organ Transplantation 2007; 12(6): 636 doi: 10.1097/MOT.0b013e3282f1fbc7
42
N. Mohsin, M. Budruddin, P. Kamble, M. Khalil, A. Pakkyarra, A. Jha, E. Mohammed, H. Ahmed, J. Ahmed, S. Thomas, J.M. Campistol, A. Daar. Complete Regression of Cutaneous B-Cell Lymphoma in a Renal Transplant Patient After Conversion From Cyclosporin to SirolimusTransplantation Proceedings 2007; 39(4): 1267 doi: 10.1016/j.transproceed.2007.03.092
43
Zheng Wang, Jian Zhou, Jia Fan, Shuang-Jian Qiu, Yao Yu, Xiao-Wu Huang, Zhao-You Tang. Effect of Rapamycin Alone and in Combination with Sorafenib in an Orthotopic Model of Human Hepatocellular CarcinomaClinical Cancer Research 2008; 14(16): 5124 doi: 10.1158/1078-0432.CCR-07-4774
44
S. Fayek, D. Moore, K.H. Bortecen, H. Yeh, J.F. Markmann, K.M. Olthoff, A. Shaked. Liver Transplantation in the Setting of Extra-Hepatic Malignancy: Two Case ReportsTransplantation Proceedings 2007; 39(10): 3512 doi: 10.1016/j.transproceed.2007.09.007
45
A. Moreno, R. Bárcena, M. García-Gonzalez, F. García-Hoz, C. Quereda, J.L. Casado, M.J. Pérez-Elías, J. Fortún, J. Nuño, I. Arranz, S. Moreno. Severe Sirolimus-Related Inflammatory State Anemia in an HIV+ Liver Transplant Patient With Calcineurin Inhibitor Renal Insufficiency: A Case ReportTransplantation Proceedings 2008; 40(10): 3810 doi: 10.1016/j.transproceed.2008.07.130
46
Martin-Walter Welker, Wolf-Otto Bechstein, Stefan Zeuzem, Joerg Trojan. Recurrent hepatocellular carcinoma after liver transplantation - an emerging clinical challengeTransplant International 2013; 26(2): 109 doi: 10.1111/j.1432-2277.2012.01562.x
47
Gerhard Treiber. mTOR inhibitors for hepatocellular cancer: a forward-moving targetExpert Review of Anticancer Therapy 2009; 9(2): 247 doi: 10.1586/14737140.9.2.247
48
Kyung-Suk Suh, Hae Won Lee. Liver Transplantation for Advanced Hepatocellular Carcinoma: How Far Can We Go?Hepatic Oncology 2015; 2(1): 19 doi: 10.2217/hep.14.34
49
A.O. Ferreiro, M.A. Vazquez-Millán, F.S. López, M.G. Gutiérrez, S.P. Diaz, M.J.L. Patiño. Everolimus-Based Immunosuppression in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Liver Transplantation: A Case SeriesTransplantation Proceedings 2014; 46(10): 3496 doi: 10.1016/j.transproceed.2014.08.045
50
A. Hollebecque, T. Decaens, E. Boleslawski, P. Mathurin, C. Duvoux, F.-R. Pruvot, S. Dharancy. Natural history and therapeutic management of recurrent hepatocellular carcinoma after liver transplantationGastroentérologie Clinique et Biologique 2009; 33(5): 361 doi: 10.1016/j.gcb.2009.02.036
51
Anantha K. Nuthalapati, Steven I. Hanish, Paul J. Thuluvath. Disease Recurrence After Liver Transplantation2016; : 153 doi: 10.1007/978-1-4939-2947-4_11